The effect of adjunctive cariprazine on symptoms of anhedonia in patients with major depressive disorder
In patients with MDD and moderate-to-severe anhedonia, adjunctive cariprazine improved symptoms of general depression and anhedonia, suggesting a potential benefit for patients with this clinically significant symptom.
Authors
- Julie L. Adams
- Majid Kerolous
- Vladimir Maletic
- Prakash S. Masand (ORCID: https://orcid.org/0000-0003-1973-9449)
- Anna C. Wilson (ORCID: https://orcid.org/0000-0001-8672-068X)
- Jun Yu (ORCID: https://orcid.org/0009-0006-3920-9321)
- Roger S. McIntyre
Institutions
- University of South Carolina (US)
- AbbVie (United States) (US)
- Duke-NUS Medical School (SG)
- Brain and Cognition Discovery Foundation (CA)
Publication Details
- Journal
- Journal of Affective Disorders
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1016/j.jad.2025.05.026
- Citations
- 5
- Primary Topic
- Tryptophan and brain disorders
- Type
- article
- Field-Weighted Citation Impact
- 2.89